Carmat SA (EPA:ALCAR)

Market Cap	20.63M
Revenue (ttm)	7.34M
Net Income (ttm)	-51.40M
Shares Out	58.95M
EPS (ttm)	-1.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	89,185
Average Volume	1,159,616
Open	0.3600
Previous Close	0.3500
Day's Range	0.3500 - 0.3710
52-Week Range	0.2300 - 2.9900
Beta	1.39
RSI	37.04
Earnings Date	Sep 30, 2025

About Carmat

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 153
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALCAR

Financial Performance

In 2024, Carmat's revenue was 7.34 million, an increase of 91.40% compared to the previous year's 3.84 million. Losses were -51.40 million, -4.59% less than in 2023.